Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve unaudited financial results for the quarter / half year ended on September 30, 2026.

October 19, 2026 Listing Department Code: 532321 BSE LIMITED P J Towers, Dalal Street, Mumbai–400 001 Listing Department Code: Zyduslife NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, C/1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai–400 051 Sub: Notice of the meeting of Board of Directors Ref.: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”) Dear Sir, Pursuant to the provisions of regulation 29(1) of the Listing Regulations, we hereby inform that the meeting of the Board of Directors of Zydus Lifesciences Limited (“the Company”) will be held on Wednesday, November 4, 2026, to consider, apart from other agenda items, approval of unaudited financial results for the quarter / half year ended on September 30, 2026. The trading window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed till Friday, November 6, 2026, and shall open for trading on and from Monday, November 9, 2026, for all the Directors and Designated Persons of the Company. Kindly take note of the same. Thanking you, Yours faithfully, For, Zydus Lifesciences Limited Dhaval N. Soni Company Secretary and Compliance Officer Membership No. FCS7063